|
시장보고서
상품코드
1150073
세계의 췌장암 시장-시장 점유율, 규모, 동향, 산업 분석 : 치료 유형별, 진단별, 암 유형별, 최종 사용자별, 지역별, 부문 예측(2022-2030년)Pancreatic Cancer Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, & Others); By Diagnosis; By Cancer Type, By End-Users; By Region; Segment Forecast, 2022 - 2030 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
세계의 췌장암(Pancreatic Cancer) 시장 규모는 2030년에 704만 달러에 달할 것으로 예측됩니다.
세계의 췌장암 시장을 조사했으며, 시장 개요/시장 규모 및 예측/동향/촉진 요인·억제 요인/치료 유형별·진단별·암 유형별·최종 사용자별·지역별 분석/기업 개요 등 정보를 제공합니다.
목차
제1장 소개
- 리포트 설명
- 조사의 목적
- 시장 범위
- 전제 조건
- 이해관계자
제2장 주요 요약
- 시장의 하이라이트
제3장 조사 방법
- 개요
- 데이터 마이닝
- 정보원
- 1차 정보
- 2차 정보
제4장 세계의 췌장암 시장 통찰
- 췌장암-산업 스냅샷
- 췌장암 시장 역학
- 촉진 요인과 기회
- 억제 요인과 과제
- Porter’s Five Forces
- 공급기업의 협상력
- 신규 참가자의 위협
- 구매자의 협상력
- 대체품의 위협
- 기존 기업 간의 경쟁력
- PESTLE 분석
- 췌장암 산업의 동향
- 밸류체인 분석
- COVID-19 영향 분석
제5장 세계의 췌장암 시장 : 치료 유형별
- 주요 조사 결과
- 소개
- 세계의 췌장암 시장, 치료 유형별(2018-2030년)
- 화학 요법
- 세계의 췌장암 시장, 화학 요법별, 지역별(2018-2030년)
- 표적 요법
- 세계의 췌장암 시장, 표적 요법별, 지역별(2018-2030년)
- 면역 요법
- 세계의 췌장암 시장, 면역 요법별, 지역별(2018-2030년)
- 호르몬 요법
- 세계의 췌장암 시장, 호르몬 요법별, 지역별(2018-2030년)
- 기타
- 세계의 췌장암 시장, 기타별, 지역별(2018-2030년)
제6장 세계의 췌장암 시장 : 암 유형별
- 주요 조사 결과
- 소개
- 세계의 췌장암 시장, 암 유형별(2018-2030년)
- 외분비 암
- 세계의 췌장암 시장, 외분비 암별, 지역별(2018-2030년)
- 내분비 암
- 세계의 췌장암 시장, 내분비 암별, 지역별(2018-2030년)
제7장 세계의 췌장암 시장 : 진단별
- 주요 조사 결과
- 소개
- 세계의 췌장암 시장, 진단별(2018-2030년)
- 혈액 검사
- 세계의 췌장암 시장, 혈액 검사별, 지역별(2018-2030년)
- 생검
- 세계의 췌장암 시장, 생검별, 지역별(2018-2030년)
- 영상 검사
- 세계의 췌장암 시장, 영상 검사별, 지역별(2018-2030년)
- 초음파
- 세계의 췌장암 시장, 초음파별, 지역별(2018-2030년)
- 컴퓨터 단층 촬영(CT) 스캔
- 세계의 췌장암 시장, 컴퓨터 단층 촬영(CT) 스캔별, 지역별(2018-2030년)
- 자기 공명 영상법(MRI)
- 세계의 췌장암 시장, 자기 공명 화상법(MRI)별, 지역별(2018-2030년)
- 양전자 방출 단층 촬영(PET) 스캔
- 세계의 췌장암 시장, 양전자 방출 단층 촬영법(PET) 스캔별, 지역별(2018-2030년)
- 기타
- 세계의 췌장암 시장, 기타별, 지역별(2018-2030년)
제8장 세계의 췌장암 시장 : 최종 사용자별
- 주요 조사 결과
- 소개
- 세계의 췌장암 시장, 최종 사용자별(2018-2030년)
- 병원
- 세계의 췌장암 시장, 병원별, 지역별(2018-2030년)
- 전문 클리닉
- 세계의 췌장암 시장, 전문 클리닉별, 지역별(2018-2030년)
- 재택 의료
- 세계의 췌장암 시장, 재택 의료별, 지역별(2018-2030년)
- 기타
- 세계의 췌장암 시장, 기타별, 지역별(2018-2030년)
제9장 세계의 췌장암 시장 : 지역별
- 주요 조사 결과
- 소개
- 췌장암 시장의 평가, 지역별(2018-2030년)
- 췌장암 시장-북미
- 북미 : 췌장암 시장, 치료 유형별(2018-2030년)
- 북미 : 췌장암 시장, 최종 사용자별(2018-2030년)
- 북미 : 췌장암 시장, 암 유형별(2018-2030년)
- 북미 : 췌장암 시장, 진단별(2018-2030년)
- 췌장암 시장-미국
- 췌장암 시장-캐나다
- 췌장암 시장-유럽
- 유럽 : 췌장암 시장, 치료 유형별(2018-2030년)
- 유럽 : 췌장암 시장, 최종 사용자별(2018-2030년)
- 유럽 : 췌장암 시장, 암 유형별(2018-2030년)
- 유럽 : 췌장암 시장, 진단별(2018-2030년)
- 췌장암 시장-영국
- 췌장암 시장-프랑스
- 췌장암 시장-독일
- 췌장암 시장-이탈리아
- 췌장암 시장-스페인
- 췌장암 시장-네덜란드
- 췌장암 시장-러시아
- 췌장암 시장-아시아 태평양
- 아시아 태평양 : 췌장암 시장, 치료 유형별(2018-2030년)
- 아시아 태평양 : 췌장암 시장, 최종 사용자별(2018-2030년)
- 아시아 태평양 : 췌장암 시장, 암 유형별(2018-2030년)
- 아시아 태평양 : 췌장암 시장, 진단별(2018-2030년)
- 췌장암 시장-중국
- 췌장암 시장-인도
- 췌장암 시장-일본
- 췌장암 시장-말레이시아
- 췌장암 시장-인도네시아
- 췌장암 시장-한국
- 췌장암 시장-중동·아프리카
- 중동·아프리카 : 췌장암 시장, 치료 유형별(2018-2030년)
- 중동·아프리카 : 췌장암 시장, 최종 사용자별(2018-2030년)
- 중동·아프리카 : 췌장암 시장, 암 유형별(2018-2030년)
- 중동·아프리카 : 췌장암 시장, 진단별(2018-2030년)
- 췌장암 시장-사우디 아라비아
- 췌장암 시장-남아프리카
- 췌장암 시장-이스라엘
- 췌장암 시장-아랍 에미리트 연방
- 췌장암 시장-남미
- 남미 : 췌장암 시장, 치료 유형별(2018-2030년)
- 남미 : 췌장암 시장, 최종 사용자별(2018-2030년)
- 남미 : 췌장암 시장, 암 유형별(2018-2030년)
- 남미 : 췌장암 시장, 진단별(2018-2030년)
- 췌장암 시장-멕시코
- 췌장암 시장-브라질
- 췌장암 시장-아르헨티나
제10장 경쟁 상황
- 확대·인수 분석
- 확대
- 인수
- 파트너십/협업/협정/공개
제11장 기업 개요
- Amgen Incorporation
- Bayer AG
- Celgene Corporation
- Clovis Oncology Incorporation
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- GlaxoSmithKline plc
- Midatech Pharma PLC
- Novartis AG
- OncoGenex Pharmaceuticals Inc.
- Oncolytics Biotech Incorporation
- Polaris Pharmaceuticals, Inc.
- Pharmacyte Biotech Inc.
- Sun BioPharma, Inc.
- Teva Pharmaceutical Industries Ltd.
The global pancreatic cancer market size is expected to reach USD 7.04 million by 2030, according to a new study by Polaris Market Research. The report "Pancreatic Cancer Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, and Others); By Diagnosis; By Cancer Type, By End-Users; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The rising prevalence of pancreatic cancer across the globe is the primary factor boosting the market growth over the forecast period. Also, many government firms aim to improve the healthcare infrastructure by raising funding, which will further influence the market dynamics. Genetic anomalies, including the BRCA2 gene mutation, Psychiatric problems, and family atypical mole-malignant melanoma (FAMMM) syndrome, may increase the risk of cancer in the family. For instance, as per the World Cancer Research Fund International, the 12th most frequent cancer in the world is pancreatic cancer. It ranks 11th among cancers in women and 12th among cancers in men. In 2020, there were around 495,000 new instances of pancreatic cancer. Due to its difficulty in detection, pancreatic cancer typically only becomes known when it has advanced to an advanced stage.
Further, the market will be impacted by the increasing rates of diabetes and obesity, raising the chance of developing pancreatic cancer. According to the International Diabetes Foundation, a total of 537 million individuals (20-79 years old) worldwide have diabetes. By 2030, the number is reaching up to 643 million diabetics worldwide, and by 2045, there will be 783 million. Also, as per the World Obesity Organization, around 2 billion persons are overweight, and 650 million are impacted by obesity.
Another element fueling the market's expansion is an increase in R&D activity. This would offer beneficial opportunities for the growth of the market for pancreatic cancer treatments. Additionally, increasing drug releases and approvals will speed up the market's expansion. For instance, in January 2022, according to Marker Therapeutics, the FDA designated MT-601 as an orphan drug. This product is a (MultiTAA)-specific T cell designed specifically for the treatment of people with cancer.
Additionally, growing investments in the creation of cutting-edge technologies and an increase in the number of emerging markets will create more favorable conditions for expanding the market over the forecast year.
Pancreatic Cancer Market Report Highlights
Targeted Therapy segment is anticipated to grow higher over the forecast period. It is the most effective treatment option since it prevents cancer cells from growing and spreading while sparing healthy cell damage.
Exocrine pancreatic cancer segment accounted for dominating global revenue share. An exocrine pancreatic cell is a type of pancreatic cell that produces an enzyme that is discharged into the small intestine. These enzymes assist in the digestion of food as it passes through the digestive system.
Asia-Pacific is expected to grow rapidly over the projected period. Due to the rising level of disposable income in this region. Additionally, exploring healthcare infrastructure and growing government moves will accelerate this region's market's growth pace.
The global includes Amgen Incorporation, Eli Lilly and Company, GlaxoSmithKline plc, Midatech Pharma PLC, Oncolytics Biotech Incorporation, Pharmacyte Biotech Inc., Sun BioPharma, Inc., and Teva Pharmaceutical Industries Ltd
Polaris Market Research has segmented the Pancreatic Cancer market report based on treatment type, cancer type, diagnosis, end-users, and region:
Pancreatic Cancer, Treatment Type Outlook (Revenue - USD Million, 2018 - 2030)
Chemotherapy
Targeted Therapy
Immunotherapy
Hormone Therapy
Others
Pancreatic Cancer, Cancer Type Outlook (Revenue - USD Million, 2018 - 2030)
Exocrine
Endocrine
Pancreatic Cancer, Diagnosis Outlook (Revenue - USD Million, 2018 - 2030)
Blood Test
Biopsy
Imaging Tests
Ultrasound
Computerized tomography (CT) scans
Magnetic resonance imaging (MRI)
Positron emission tomography (PET) scans
Others
Pancreatic Cancer, End-Users Outlook (Revenue - USD Million, 2018 - 2030)
Hospitals
Specialty Clinics
Homecare
Others
Pancreatic Cancer, Regional Outlook (Revenue - USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Pancreatic Cancer Market Insights
- 4.1. Pancreatic Cancer - Industry Snapshot
- 4.2. Pancreatic Cancer Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing Incidence and Prevalence of Pancreatic Cancer
- 4.2.1.2. Advancements in Molecular Biology, Development of Drugs, and Diagnostic Technology
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Costs Associated with Diagnosis and Treatments
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Pancreatic Cancer Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Pancreatic Cancer Market, by Treatment Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 5.3. Chemotherapy
- 5.3.1. Global Pancreatic Cancer Market, by Chemotherapy, by Region, 2018 - 2030 (USD Million)
- 5.4. Targeted Therapy
- 5.4.1. Global Pancreatic Cancer Market, by Targeted Therapy, by Region, 2018 - 2030 (USD Million)
- 5.5. Immunotherapy
- 5.5.1. Global Pancreatic Cancer Market, by Immunotherapy, by Region, 2018 - 2030 (USD Million)
- 5.6. Hormone Therapy
- 5.6.1. Global Pancreatic Cancer Market, by Hormone Therapy, by Region, 2018 - 2030 (USD Million)
- 5.7. Others
- 5.7.1. Global Pancreatic Cancer Market, by Others, by Region, 2018 - 2030 (USD Million)
6. Global Pancreatic Cancer Market, by Cancer Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 6.3. Exocrine Cancer
- 6.3.1. Global Pancreatic Cancer Market, by Exocrine Cancer, by Region, 2018 - 2030 (USD Million)
- 6.4. Endocrine Cancer
- 6.4.1. Global Pancreatic Cancer Market, by Endocrine Cancer, by Region, 2018 - 2030 (USD Million)
7. Global Pancreatic Cancer Market, by Diagnosis
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
- 7.3. Blood Test
- 7.3.1. Global Pancreatic Cancer Market, by Blood Test, by Region, 2018 - 2030 (USD Million)
- 7.4. Biopsy
- 7.4.1. Global Pancreatic Cancer Market, by Biopsy, by Region, 2018 - 2030 (USD Million)
- 7.5. Imaging Tests
- 7.5.1. Global Pancreatic Cancer Market, by Imaging Tests, by Region, 2018 - 2030 (USD Million)
- 7.6. Ultrasound
- 7.6.1. Global Pancreatic Cancer Market, by Ultrasound, by Region, 2018 - 2030 (USD Million)
- 7.7. Computerized tomography (CT) scans
- 7.7.1. Global Pancreatic Cancer Market, by Computerized tomography (CT) scans, by Region, 2018 - 2030 (USD Million)
- 7.8. Magnetic resonance imaging (MRI)
- 7.8.1. Global Pancreatic Cancer Market, by Magnetic resonance imaging (MRI), by Region, 2018 - 2030 (USD Million)
- 7.9. Positron emission tomography (PET) scans
- 7.9.1. Global Pancreatic Cancer Market, by Positron emission tomography (PET) scans, by Region, 2018 - 2030 (USD Million)
- 7.10. Others
- 7.10.1. Global Pancreatic Cancer Market, by Others, by Region, 2018 - 2030 (USD Million)
8. Global Pancreatic Cancer Market, by End-Users
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 8.3. Hospitals
- 8.3.1. Global Pancreatic Cancer Market, by Hospitals, by Region, 2018 - 2030 (USD Million)
- 8.4. Specialty Clinics
- 8.4.1. Global Pancreatic Cancer Market, by Specialty Clinics, by Region, 2018 - 2030 (USD Million)
- 8.5. Homecare
- 8.5.1. Global Pancreatic Cancer Market, by Homecare, by Region, 2018 - 2030 (USD Million)
- 8.6. Others
- 8.6.1. Global Pancreatic Cancer Market, by Others, by Region, 2018 - 2030 (USD Million)
9. Global Pancreatic Cancer Market, by Geography
- 9.1. Key findings
- 9.2. Introduction
- 9.2.1. Pancreatic Cancer Market Assessment, By Geography, 2018 - 2030 (USD Million)
- 9.3. Pancreatic Cancer Market - North America
- 9.3.1. North America: Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 9.3.2. North America: Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 9.3.3. North America: Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 9.3.4. North America: Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
- 9.3.5. Pancreatic Cancer Market - U.S.
- 9.3.5.1. U.S.: Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 9.3.5.2. U.S.: Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 9.3.5.3. U.S.: Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 9.3.5.4. U.S.: Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
- 9.3.6. Pancreatic Cancer Market - Canada
- 9.3.6.1. Canada: Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 9.3.6.2. Canada: Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 9.3.6.3. Canada: Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 9.3.6.4. Canada: Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
- 9.4. Pancreatic Cancer Market - Europe
- 9.4.1. Europe: Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 9.4.2. Europe: Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 9.4.3. Europe: Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 9.4.4. Europe: Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
- 9.4.5. Pancreatic Cancer Market - UK
- 9.4.5.1. UK: Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 9.4.5.2. UK: Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 9.4.5.3. UK: Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 9.4.5.4. UK: Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
- 9.4.6. Pancreatic Cancer Market - France
- 9.4.6.1. France: Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 9.4.6.2. France: Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 9.4.6.3. France: Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 9.4.6.4. France: Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
- 9.4.7. Pancreatic Cancer Market - Germany
- 9.4.7.1. Germany: Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 9.4.7.2. Germany: Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 9.4.7.3. Germany: Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 9.4.7.4. Germany: Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
- 9.4.8. Pancreatic Cancer Market - Italy
- 9.4.8.1. Italy: Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 9.4.8.2. Italy: Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 9.4.8.3. Italy: Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 9.4.8.4. Italy: Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
- 9.4.9. Pancreatic Cancer Market - Spain
- 9.4.9.1. Spain: Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 9.4.9.2. Spain: Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 9.4.9.3. Spain: Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 9.4.9.4. Spain: Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
- 9.4.10. Pancreatic Cancer Market - Netherlands
- 9.4.10.1. Netherlands: Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 9.4.10.2. Netherlands: Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 9.4.10.3. Netherlands: Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 9.4.10.4. Netherlands: Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
- 9.4.11. Pancreatic Cancer Market - Russia
- 9.4.11.1. Russia: Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 9.4.11.2. Russia.: Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 9.4.11.3. Russia: Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 9.4.11.4. Russia: Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
- 9.5. Pancreatic Cancer Market - Asia Pacific
- 9.5.1. Asia Pacific: Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 9.5.2. Asia Pacific: Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 9.5.3. Asia Pacific: Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 9.5.4. Asia Pacific: Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
- 9.5.5. Pancreatic Cancer Market - China
- 9.5.5.1. China: Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 9.5.5.2. China.: Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 9.5.5.3. China: Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 9.5.5.4. China: Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
- 9.5.6. Pancreatic Cancer Market - India
- 9.5.6.1. India: Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 9.5.6.2. India.: Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 9.5.6.3. India: Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 9.5.6.4. India: Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
- 9.5.7. Pancreatic Cancer Market - Japan
- 9.5.7.1. Japan: Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 9.5.7.2. Japan.: Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 9.5.7.3. Japan: Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 9.5.7.4. Japan: Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
- 9.5.8. Pancreatic Cancer Market - Malaysia
- 9.5.8.1. Malaysia: Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 9.5.8.2. Malaysia.: Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 9.5.8.3. Malaysia: Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 9.5.8.4. Malaysia: Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
- 9.5.9. Pancreatic Cancer Market - Indonesia
- 9.5.9.1. Indonesia: Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 9.5.9.2. Indonesia.: Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 9.5.9.3. Indonesia: Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 9.5.9.4. Indonesia: Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
- 9.5.10. Pancreatic Cancer Market - South Korea
- 9.5.10.1. South Korea: Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 9.5.10.2. South Korea.: Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 9.5.10.3. South Korea: Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 9.5.10.4. South Korea: Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
- 9.6. Pancreatic Cancer Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 9.6.2. Middle East & Africa: Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 9.6.3. Middle East & Africa: Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 9.6.4. Middle East & Africa: Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
- 9.6.5. Pancreatic Cancer Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 9.6.5.2. Saudi Arabia: Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 9.6.5.3. Saudi Arabia: Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 9.6.5.4. Saudi Arabia: Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
- 9.6.6. Pancreatic Cancer Market - South Africa
- 9.6.6.1. South Africa: Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 9.6.6.2. South Africa: Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 9.6.6.3. South Africa: Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 9.6.6.4. South Africa: Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
- 9.6.7. Pancreatic Cancer Market - Israel
- 9.6.7.1. Israel: Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 9.6.7.2. Israel: Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 9.6.7.3. Israel: Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 9.6.7.4. Israel: Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
- 9.6.8. Pancreatic Cancer Market - UAE
- 9.6.8.1. UAE: Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 9.6.8.2. UAE: Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 9.6.8.3. UAE: Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 9.6.8.4. UAE: Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
- 9.7. Pancreatic Cancer Market - Latin America
- 9.7.1. Latin America: Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 9.7.2. Latin America: Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 9.7.3. Latin America: Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 9.7.4. Latin America: Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
- 9.7.5. Pancreatic Cancer Market - Mexico
- 9.7.5.1. Mexico: Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 9.7.5.2. Mexico: Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 9.7.5.3. Mexico: Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 9.7.5.4. Mexico: Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
- 9.7.6. Pancreatic Cancer Market - Brazil
- 9.7.6.1. Brazil: Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 9.7.6.2. Brazil: Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 9.7.6.3. Brazil: Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 9.7.6.4. Brazil: Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
- 9.7.7. Pancreatic Cancer Market - Argentina
- 9.7.7.1. Argentina: Pancreatic Cancer Market, by Treatment Type, 2018 - 2030 (USD Million)
- 9.7.7.2. Argentina: Pancreatic Cancer Market, by End-Users, 2018 - 2030 (USD Million)
- 9.7.7.3. Argentina: Pancreatic Cancer Market, by Cancer Type, 2018 - 2030 (USD Million)
- 9.7.7.4. Argentina: Pancreatic Cancer Market, by Diagnosis, 2018 - 2030 (USD Million)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Amgen Incorporation
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Bayer AG
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Celgene Corporation
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Clovis Oncology Incorporation
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Eli Lilly and Company
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. F. Hoffmann-La Roche AG
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. GlaxoSmithKline plc
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Midatech Pharma PLC
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Novartis AG
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. OncoGenex Pharmaceuticals Inc.
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. Oncolytics Biotech Incorporation
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
- 11.12. Polaris Pharmaceuticals, Inc.
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
- 11.13. Pharmacyte Biotech Inc.
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
- 11.14. Sun BioPharma, Inc.
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
- 11.15. Teva Pharmaceutical Industries Ltd.
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development
비교리스트